STEPWISE研究:为患有帕金森病的人提供基于智能手机的炼解决方案的研究协议 (随机对照试验).
Sabine Schootemeijer1, Nienke M de Vries1, Eric A Macklin2,3
1DisordersDonders Institute for Brain, Cognition and Behaviour, Department of Neurology, Center of Expertise for Parkinson & Movement Disorders, Radboud University Medical Center, Nijmegen, the Netherlands.
BMC neurology
|September 12, 2023
概括
一个智能手机应用程序 (STEPWISE) 旨在促进帕金森病 (PD) 患者的身体活动. 这项研究调查了它在一年内提高步数和整体功能的有效性.
科学领域:
- 神经学 神经学
- 数字健康数字健康
- 运动科学 运动科学
背景情况:
- 帕金森病 (PD) 患者面临着坚持炼方案的挑战.
- 可持续的参与需要激励,可访问和可扩展的干预措施.
- 智能手机应用程序为增加身体活动提供了一个潜在的解决方案.
研究的目的:
- 为了评估STEPWISE智能手机应用程序是否会在52周内增加PD患者的每日步数.
- 评估干预对身体健康,运动功能和非运动症状的影响.
- 探索体育活动量和二次结果之间的剂量反应关系.
主要方法:
- 这是一项双盲随机对照试验,涉及452名荷兰PD患者 (Hoehn & Yahr 1-3阶段).
- 基线步数低于7,000/天的参与者被随机分配到控制组或干预组,每组有不同的步数增加目标 (25-400%).
- 主要终点:52周通过STEPWISE应用程序改变步数;次要终点包括健身和运动/非运动功能.
主要成果:
- 该研究正在评估STEPWISE应用程序在增加PD患者身体活动水平方面的潜力.
- 分析将重点关注步数变化和与次要结果的关联的群体间差异.
- 结果尚未公布,但试验设计允许对干预的有效性进行可靠的评估.
结论:
- 该STEPWISE试验评估了基于智能手机的干预措施,以增加帕金森病患者的身体活动.
- 激励应用程序可能会提高对炼建议的坚持.
- 这种方法可以促进PD运动干预的远程临床试验.
相关概念视频
01:24Parkinson's Disease: Treatment
295
Neurodegenerative disorders, such as Parkinson's Disease (PD), involve the gradual and irreversible destruction of neurons in particular brain areas. These disorders exhibit standard features like proteinopathies, selective vulnerability of some neurons, and an interaction of intrinsic properties, genetics, and environmental influences in neural injury.
Parkinson's Disease is primarily a result of the loss of dopaminergic neurons in the substantia nigra pars compacta. The cornerstone of...
Parkinson's Disease is primarily a result of the loss of dopaminergic neurons in the substantia nigra pars compacta. The cornerstone of...
295
01:15Parkinson's Disease: Overview
592
Neurodegenerative disorders are progressive diseases that cause irreversible damage and loss to neurons in specific brain areas. Examples of these disorders include Parkinson's disease, Alzheimer's disease, Multiple Sclerosis (MS), and Amyotrophic Lateral Sclerosis (ALS). These disorders share characteristics such as proteinopathies, selective neuronal vulnerability, and a complex interplay between genetic and environmental factors. The primary therapeutic goal for these conditions is...
592